EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells

Shaochuan Zhang iD, Bisei Ohkawara, Mikako Ito, Zhizhou Huang, Fei Zhao, Tomohiko Nakata, Tomoya Takeuchi, Hidetoshi Sakurai, Hirofumi Komaki, Masayoshi Kamon, Toshiyuki Araki iD, Kinji Ohno iD

Human Molecular Genetics · 2023

DOI: 10.1093/hmg/ddac306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Shaochuan Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myasthenic Syndromes, Congenital. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center of Neurology and Psychiatry, Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

At the neuromuscular junction, the downstream of tyrosine kinase 7 (DOK7) enhances the phosphorylation of muscle-specific kinase (MuSK) and induces clustering of acetylcholine receptors (AChRs). We identified a patient with congenital myasthenic syndrome (CMS) with two heteroallelic mutations in DOK7, c.653-1G>C in intron 5 and c.190G>A predicting p.G64R in the pleckstrin homology domain. iPS cells established from the patient (CMS-iPSCs) showed that c.653-1G>C caused in-frame skipping of exon 6 (120 bp) and frame-shifting activation of a cryptic splice site deleting seven nucleotides in exon 6. p.G64R reduced the expression of DOK7 to 10% of wild-type DOK7, and markedly compromised AChR clustering in transfected C2C12 myotubes. p.G64R-DOK7 made insoluble aggresomes at the juxtanuclear region in transfected C2C12 myoblasts and COS7 cells, which were co-localized with molecules in the autophagosome system. A protease inhibitor MG132 reduced the soluble fraction of p.G64R-DOK7 and enhanced the aggresome formation of p.G64R-DOK7. To match the differentiation levels between patient-derived and control induced pluripotent stem cells (iPSCs), we corrected c.190G>A (p.G64R) by CRISPR/Cas9 to make isogenic iPSCs while retaining c.653-1G>C (CMS-iPSCsCas9). Myogenically differentiated CMS-iPSCs showed juxtanuclear aggregates of DOK7, reduced expression of endogenous DOK7 and reduced phosphorylation of endogenous MuSK. Another mutation, p.T77M, also made aggresome to a less extent compared with p.G64R in transfected COS7 cells. These results suggest that p.G64R-DOK7 makes aggresomes in cultured cells and is likely to compromise MuSK phosphorylation for AChR clustering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsMyasthenic Syndromes, CongenitalHumansCells, CulturedMuscle ProteinsMutationPhosphorylationReceptors, CholinergicReceptor Protein-Tyrosine Kinases

Substanzen

Muscle ProteinsReceptors, CholinergicDOK7 protein, humanMUSK protein, humanReceptor Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
  • Department of Pediatrics, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.
  • Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.

ORCID-Profile: Shaochuan Zhang, Toshiyuki Araki, Kinji Ohno

Förderung

  • National Center of Neurology and Psychiatry
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Zhang, S., Ohkawara, B., Ito, M., Huang, Z., Zhao, F., Nakata, T., Takeuchi, T., Sakurai, H., Komaki, H., Kamon, M., Araki, T., & Ohno, K. (2023). A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac306

Vancouver

Zhang S, Ohkawara B, Ito M, Huang Z, Zhao F, Nakata T, et al. A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac306

BibTeX
@article{Zhang2023,
  author = {Zhang, Shaochuan and Ohkawara, Bisei and Ito, Mikako and Huang, Zhizhou and Zhao, Fei and Nakata, Tomohiko and Takeuchi, Tomoya and Sakurai, Hidetoshi and Komaki, Hirofumi and Kamon, Masayoshi and Araki, Toshiyuki and Ohno, Kinji},
  title = {A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells},
  journal = {Human Molecular Genetics},
  year = {2023},
  doi = {10.1093/hmg/ddac306}
}
Kostenlos starten →